Idiopathic Immunodeficiency in Cytomegalovirus Reactivation: A Rare Case
Abstract
Idiopathic CD4 lymphocytopenia (ICL) is a rare condition characterized by an unexplained deficit of circulating CD4 T cells leading to increased risk of serious opportunistic infections. Reactivation and severe symptomatic CMV is also a rare case, except in immunocompromised patient. Patient concerns are 36-year-old male patient complained seizure, fever, cough, and dyspnea. History of chronic urticaria and prolonged Mebhydrolin consumption. HIV was negative. CD4 was low. Diagnosis in this case is Viral encephalitis, Viral pneumonitis, CMV reactivation, hemophagocytic lymphohistiocytosis immunodeficiency state. The results in this study indicate that the patients were treated with conventional therapies for Severe CMV infection with Acyclovir. Steroid was given for the last five days. The first day after administration of therapy showed clinical and laboratory improvement. Laboratory values returned to normal values on the fifth day of therapy. Since the second day after the therapy was given, the patient had no complaints. In cases of CMV reactivation, an immunodeficiency condition should be suspected. A comprehensive history, physical examination, laboratory and radiological examination, adequate therapy and and policy support are required to establish a definite diagnosis and reduce the risk of mortality.
References
A Ross, S., Novak, Z., Pati, S., & B Boppana, S. (2011). Overview of the Diagnosis of Cytomegalovirus Infection. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders), 11(5), 466-474.
Ayub, M. T., Jafar, M. S., Khalid, M., Baig, M. A., & Mba, B. (2018). Suppressed without a Cause: A Case of Idiopathic Immune Deficiency. Cureus, 10(1).
Barkholt, L., Lewensohn‐Fuchs, I., Ericzon, B. G., Tyden, G., & Andersson, J. (1999). High‐Dose Acyclovir Prophylaxis Reduces Cytomegalovirus Disease in Liver Transplant Patients. Transplant Infectious Disease, 1(2), 89-97.
Bonalumi, S., Trapanese, A., Santamaria, A., D’Emidio, L., & Mobili, L. (2011). Cytomegalovirus Infection in Pregnancy: Review of the Literature. Journal of Prenatal Medicine, 5(1), 1.
Da Cunha, T., & Wu, G. Y. (2021). Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts. Journal of Clinical and Translational Hepatology, 9(1), 106.
Decrion, A. Z., Dichamp, I., Varin, A., & Herbein, G. (2005). HIV and Inflammation. Current HIV research, 3(3), 243-259.
Döcke, W. D., Fietze, E., Syrbe, U., von Baehr, R., Volk, H. D., Prösch, S., ... & Klug, C. (1994). Cytomegalovirus Reactivation and Tumour Necrosis Factor. The Lancet, 343(8892), 268-269.
Furuta, Y., Miyamoto, H., Naoe, H., Shimoda, M., Hinokuma, Y., Miyamura, T., ... & Sasaki, Y. (2020). Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis. Case Reports in Gastroenterology, 14(1), 103-109.
Gleeson, M. (2013). Exercise, Nutrition and Immunity. In Diet, Immunity and Inflammation (pp. 652-685). Woodhead Publishing.
Griffiths, P., Baraniak, I., & Reeves, M. (2015). The Pathogenesis of Human Cytomegalovirus. The Journal of Pathology, 235(2), 288-297.
Limaye, A. P., Kirby, K. A., Rubenfeld, G. D., Leisenring, W. M., Bulger, E. M., Neff, M. J., ... & Boeckh, M. (2008). Cytomegalovirus Eeactivation in Critically Ill Immunocompetent Patients. Jama, 300(4), 413-422.
McCusker, C., & Warrington, R. (2011). Primary Immunodeficiency. Allergy, Asthma & Clinical Immunology, 7(1), 1-8.
McEwen, J., & Strickland, W. J. (1982). Mebhydrolin Napadisylate A Possible Cause of Reversible Agranulocytosis and Neutropenia. Medical Journal of Australia, 2(11), 523-525.
Munro, M., Yadavalli, T., Fonteh, C., Arfeen, S., & Lobo-Chan, A. M. (2019). Cytomegalovirus Retinitis in HIV and non-HIV Individuals. Microorganisms, 8(1), 55.
Raman, J., Braunlich, K., Welborn, M., Hooey, L., & Motaparthi, K. (2022). Cytomegalovirus Infection Presenting as an Isolated Petechial Eruption in an Immunocompromised Patient. JAAD Case Reports, 20, 6-9.
Reischig, T., Kacer, M., Jindra, P., Hes, O., Lysak, D., & Bouda, M. (2015). Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation. Clinical Journal of the American Society of Nephrology, 10(2), 294-304.
Tan, B. H. (2014). Cytomegalovirus Treatment. Current Treatment Options in Infectious Diseases, 6(3), 256-270.
Tse, J. R., & Ng, G. X. (2014). Pancytopenia Secondary to Cytomegalovirus Reactivation. Case Reports, 2014, bcr2013201857.
Varani, S., & Landini, M. P. (2011). Cytomegalovirus-Induced Immunopathology and Its Clinical Consequences. Herpesviridae, 2(1), 1-14.
Yarmohammadi, H., & Cunningham-Rundles, C. (2017). Idiopathic CD4 Lymphocytopenia: Pathogenesis, Etiologies, Clinical Presentations and Treatment Strategies. Annals of Allergy, Asthma & Immunology, 119(4), 374-378.
Zhang, Z., Liu, X., Sang, L., Chen, S., Wu, Z., Zhang, J., ... & Liu, X. (2021). Cytomegalovirus Reactivation in Immunocompetent Mechanical Ventilation Patients: A Prospective Observational Study. BMC Infectious Diseases, 21(1), 1-10.
Copyright (c) 2022 International Journal of Science and Society
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.png)
.jpg)
.png)
.png)
.png)
.png)
1.png)
.jpg)
-modified.png)
-modified.png)
-modified.png)
